BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.

Biotechnology

Health Care

Life Sciences

Medical Devices

BioStem Technologies (OTC: BSEM)

Jason Matuszewski

Wendy Weston

Taylor Sabol

Neal Bhattacharya

Shawn Mccarrey

Michael Fortunato

The Leadership Team at BioStem Technologies is responsible for setting the strategic direction and vision of the company, ensuring operational excellence and financial sustainability. This team collaborates to drive innovation in regenerative therapies, oversees marketing and commercial initiatives to expand product reach, and guides research and development efforts to enhance the efficacy of allograft products. Together, they uphold the company’s commitment to quality and compliance with industry standards, ultimately aiming to transform lives through advanced healthcare solutions.

Leadership Team

Finance and Accounting

Leadership Team

About

Team members

Other teams at BioStem Technologies (OTC: BSEM)

Finance and Accounting